By Michael Jaasma, PhD, Co-founder and Chief Scientific Officer at Osteoboost Health A few weeks ago, I was interviewed for an article in Women’s Health magazine about the pros and cons of weighted vests for improving bone health. I have seen several other articles and social media posts about weighted…
Read more
First-of-its-kind FDA-cleared precision vibration therapy wearable device to treat millions at risk of fracture from osteopenia REDWOOD CITY, CALIF – December 4, 2024 – Bone Health Technologies (BHT), a leading medical technology startup developing innovative non-pharmacological solutions to improve bone health and reduce fractures, today announced that pre-orders are now…
Read more
One of the biggest challenges of aging is the loss of bone density, which too often leads to osteoporosis and serious fractures that significantly impact quality of life. Our mission with Osteoboost is to slow the process of bone loss and preserve bone density and strength, helping people live stronger,…
Read more
Last week I had the honor of presenting Osteoboost, our soon-to-launch FDA-cleared precision vibration therapy medical device, at the 2024 Hitlab Women’s Health Tech event held on October 11. And I’m thrilled to report that Osteoboost won both first place in the seed-stage category and the event’s People’s Choice Award!…
Read more
Almost four years ago, I had my second dexa scan and got the news that I have learned is typical: in the five years after menopause, my bone density went from normal to osteopenia. I lost 13% of my bone density in my spine. I got a weirdly chipper note…
Read more
Bone Health Technologies takes a pivotal step toward a future of comprehensive one-stop bone health care for patients everywhere REDWOOD CITY, Calif. (July 25, 2024) – Bone Health Technologies (BHT), a leading medical technology innovator developing breakthrough non-pharmacological solutions to improve bone health and reduce fractures, today announced the company…
Read more
REDWOOD CITY, CA (July 2, 2024) – Bone Health Technologies (BHT), a leading medtech innovator developing breakthrough noninvasive and drug-free solutions for low bone density, today announced the company has been awarded a fifth patent for Osteoboost—the first and only FDA-cleared prescription medical device to treat osteopenia. The patent, US…
Read more
